<p>October is Brain Tumour Awareness Month</p>
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes.
Dr. Brenda Milner, an active researcher at the age of 95 at the Montreal Neurological Institute and Hospital - The Neuro, McGill University, is a recipient of The 2014 Kavli Prize in Neuroscience.
Timing is everything: scientists control rapid re-wiring of brain circuits using patterned visual stimulation
In a new study, published in this week’s issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli. In most neuroscience textbooks today, there is a widely held model that explains how nerve circuits might refine their connectivity based on patterned firing of brain cells, but it has not previously been directly observed in real time.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and McGill University Health Centre, is being awarded the Prix d’excellence 2014 by the Collège des médecins du Québec, for his outstanding contributions to neurogenetics and medicine. Dr. Rouleau accepts the award today at a ceremony at the Chateau Frontenac in Quebec City. TRIBUTE VIDEO: http://bit.ly/1np0tJH
People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation.
The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease. New Rapid-Access Clinic at The Neuro reduces wait time
The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The “Montreal Procedure” developed by Dr. Wilder Penfield and colleagues revolutionized the surgical treatment for epilepsy, allowing thousands of patients to start new lives free of seizures. The use of electroencephalography (EEG) and magnetic resonance imaging (MRI) for the study and treatment of epilepsy was pioneered at The Neuro.
Montreal scientists play key role in long-term international study Rate of change in the thickness of the brain’s cortex is an important factor associated with a person’s change in IQ, according to a collaborative study by scientists in five countries including researchers at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the McGill University Health Centre.
MS Society of Canada and MS Scientific Research Foundation announce $3.6 million grant to understanding B cells for future MS therapies The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced a $3.6 million grant to investigate the role of the B cell, a type of white blood cell of the immune system, in contributing to the development and propagation of multiple sclerosis.
Dr. Brenda Milner, an active researcher at the age of 95 at the Montreal Neurological Institute and Hospital, McGill University, has been awarded the 2014 Dan David Prize for her fundamental contributions to the science of memory and the brain. Dr. Milner is widely recognized as one of the founders of cognitive neuroscience–the field that brings together brain and behavior. Dr. Milner, who is the Dorothy J. Killam Professor of Psychology, shares the Prize for the category Present: “Combatting Memory Loss”, with Peter St. George-Hyslop (University of Cambridge) and John A.
Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson’s disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in The EMBO Journal, removes damaged proteins that arise from oxidative stress from mitochondria.
William Feindel, O.C., G.O.Q., MDCM, D. Phil 1918 – 2014 The Montreal Neurological Institute and Hospital, McGill University and the McGill University Health Centre regret to announce the death of William Feindel, O.C., G.O.Q., MDCM, D. Phil., one of Canada's most distinguished neurosurgeons and The Neuro’s third director. Dr. Feindel passed away quietly at The Neuro on Sunday night following a brief illness. Our deepest sympathies go out to Dr. Feindel’s family.
The BigBrain atlas developed by Dr. Alan Evans and colleagues at The Neuro’s Brain Imaging Centre has been chosen as one of the top 10 discoveries of the year in Quebec Science. BigBrain: a revolutionary new 3D digital brain atlas